EU expands label for Tandem insulin delivery systems
Tandem Diabetes Care received EU approval to expand the label for its t:slim X2 and Tandem Mobi automated insulin delivery systems, allowing broader use in diabetes management.
Diabetes and metabolic health news covering Type 1 and 2 diabetes, GLP-1 drugs, insulin access, and obesity science.
Tandem Diabetes Care received EU approval to expand the label for its t:slim X2 and Tandem Mobi automated insulin delivery systems, allowing broader use in diabetes management.